If you have commercial insurance
The cheapest path is almost always:
- Confirm coverage of a GLP-1 medication for your indication (diabetes or weight management) on your plan formulary.
- Apply the manufacturer savings card. NovoCare for Ozempic, Wegovy, Rybelsus, Saxenda, Victoza. LillyDirect for Mounjaro, Zepbound.
- Complete any prior authorization documentation with your prescriber.
For commercially insured patients meeting eligibility, out-of-pocket cost is commonly $25-$100 per month with the savings card.
If you do not have insurance covering GLP-1
Three primary self-pay pathways:
1. Manufacturer direct-to-consumer programs
- LillyDirect (Zepbound): Eli Lilly's direct-to-consumer channel sells single-dose Zepbound vials at approximately $349-$499 per month, depending on dose strength and supply. Sign-up is through LillyDirect.com after a clinician writes a prescription.
- NovoCare (Wegovy): Novo Nordisk introduced direct cash-pay options in 2025 to compete with compounded options; pricing has been roughly $499-$650 per month for self-pay through this channel.
2. Compounded GLP-1 through telehealth
- Compounded semaglutide: $150-$400/month bundled with telehealth clinical care.
- Compounded tirzepatide: $200-$500/month bundled.
- Available where legally permitted under current FDA shortage status and state pharmacy law. See compounded semaglutide and compounded tirzepatide.
3. Patient assistance programs
- NovoCare Patient Assistance Program provides free Novo Nordisk medications to qualifying low-income uninsured patients.
- Lilly Cares Foundation provides similar assistance for Eli Lilly products.
- NeedyMeds, RxAssist, and similar nonprofits aggregate patient assistance program eligibility tools.
Income criteria typically require household income at or below 300-500% of the federal poverty level depending on program.
See your lowest-cost option
A telehealth clinician can review your insurance status, eligibility, and the most affordable GLP-1 path for your situation.
See If You Qualify →Sponsored link. We earn a commission when you sign up. Medical eligibility determined by licensed providers. Disclosure
Self-pay cost comparison
| Option | Active ingredient | Monthly cost | Notes |
|---|---|---|---|
| Brand-name retail (no insurance) | Various | $1,000-$1,400 | Without any discount |
| NovoCare cash-pay Wegovy | Semaglutide 2.4 mg | ~$499-$650 | Direct from manufacturer |
| LillyDirect Zepbound | Tirzepatide | ~$349-$499 | Lower vial strengths cheaper |
| Compounded semaglutide | Semaglutide | $150-$400 | Via telehealth, where legal |
| Compounded tirzepatide | Tirzepatide | $200-$500 | Via telehealth, where legal |
| Patient assistance (eligible patients) | Brand-name | Free or near-free | Income criteria apply |
GoodRx, pharmacy price comparison
GoodRx and similar tools can reveal pharmacy-to-pharmacy price differences, but GLP-1 list prices are relatively standardized across major retail pharmacies. The bigger savings come from manufacturer savings cards and direct-to-consumer manufacturer channels rather than retail price shopping.
International pharmacy considerations
Some GLP-1 medications are available at lower prices in Canada, Mexico, and other countries. Importing prescription medication into the US for personal use exists in a regulatory gray area. FDA generally does not enforce against small personal-use imports but reserves the right to do so. Risks include counterfeit product, customs seizure, and lack of clinical oversight. Not recommended as a primary strategy without consulting a clinician and understanding the legal landscape.
Why "research peptides" are not a safe cheap option
Suppliers selling "research peptide" semaglutide or tirzepatide labeled "not for human use" are not legitimate sources for personal medication use. Risks include unknown purity, contamination, counterfeit product, mislabeled salt forms (semaglutide sodium rather than base), and complete lack of clinical oversight. FDA has issued repeated warnings.
HSA and FSA
Prescription GLP-1 medications are generally eligible expenses for Health Savings Accounts and Flexible Spending Accounts. This provides a tax-advantaged way to pay for the medication (effectively a 20-30% discount depending on your marginal tax rate). Compounded GLP-1 prescribed by a licensed clinician for a qualifying medical purpose is generally HSA/FSA eligible; verify with your plan administrator.
Bottom line on the cheapest GLP-1
- Commercially insured patients: savings card + insurance = lowest cost ($25-$100/mo).
- Self-pay, brand-name preferred: LillyDirect Zepbound or NovoCare cash-pay Wegovy ($349-$650/mo).
- Self-pay, cost-prioritized: compounded semaglutide or tirzepatide via telehealth ($150-$500/mo) where legally available.
- Low-income uninsured: manufacturer patient assistance programs (free or near-free).
The right answer depends on your situation. A telehealth clinician familiar with the current landscape can help you compare options.
Find your lowest-cost option
A licensed clinician can match you to the most affordable legitimate GLP-1 pathway for your situation.
Check Your Eligibility →Sponsored link. We earn a commission when you sign up. Medical eligibility determined by licensed providers. Disclosure